Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value

$10.86−0.13 (-1.18%)

Close on Nov 12, 2026Market cap $913.24MP/E 13.6Yield –

Bioventus total assets

Total assets on the balance sheet at the end of each period.

Bioventus's total assets was $673.43M at Sep 26, 2026. For fiscal 2025 it was $683.56M, down 6.1% from the year before. The highest annual figure on record is $1.37B in fiscal 2022.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$683.56M	-6.1%
FY2024	Dec 31, 2024	$727.96M	-10.2%
FY2023	Dec 31, 2023	$810.91M	-40.9%
FY2022	Dec 31, 2022	$1.37B	+12.0%
FY2021	Dec 31, 2021	$1.23B	+147.9%
FY2020	Dec 31, 2020	$494.47M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 26, 2026	$673.43M	-4.0%
Q2 FY2026	Jun 27, 2026	$673.35M	-4.7%
Q1 FY2026	Mar 28, 2026	$650.54M	-5.9%
Q4 FY2025	Dec 31, 2025	$683.56M	-6.1%
Q3 FY2025	Sep 27, 2025	$701.59M	-8.8%
Q2 FY2025	Jun 28, 2025	$706.79M	-10.8%
Q1 FY2025	Mar 29, 2025	$691.41M	-12.9%
Q4 FY2024	Dec 31, 2024	$727.96M	-10.2%
Q3 FY2024	Sep 28, 2024	$769.49M	-5.1%
Q2 FY2024	Jun 29, 2024	$792.17M	-5.4%
Q1 FY2024	Mar 30, 2024	$794.24M	-10.5%
Q4 FY2023	Dec 31, 2023	$810.91M	-40.9%
Q3 FY2023	Sep 30, 2023	$811.10M	-42.0%
Q2 FY2023	Jul 1, 2023	$836.96M	-30.8%
Q1 FY2023	Apr 1, 2023	$887.40M	-25.9%
Q4 FY2022	Dec 31, 2022	$1.37B	+12.0%
Q3 FY2022	Oct 1, 2022	$1.40B	+113.5%
Q2 FY2022	Jul 2, 2022	$1.21B	+86.9%
Q1 FY2022	Apr 2, 2022	$1.20B	+86.2%
Q4 FY2021	Dec 31, 2021	$1.23B	+147.9%
Q3 FY2021	Oct 2, 2021	$654.79M	–
Q2 FY2021	Jul 3, 2021	$646.64M	–
Q1 FY2021	Apr 3, 2021	$643.08M	–
Q4 FY2020	Dec 31, 2020	$494.47M	–